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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe SWI/SNF complex plays an important role in mouse embryonic stem cells (mESCs), but it remains to be determined whether this
complex is required for the pluripotency of human ESCs (hESCs). Using RNAi, we demonstrated that depletion of BRG1, the catalytic
subunit of the SWI/SNF complex, led to impaired self-renewing ability and dysregulated lineage specification of hESCs. A unique compo-
sition of the BRG1-SWI/SNF complex in hESCs was further defined by the presence of BRG1, BAF250A, BAF170, BAF155, BAF53A, and
BAF47. Genome-wide expression analyses revealed that BRG1 participated in a broad range of biological processes in hESCs through
pathways different from those in mESCs. In addition, chromatin immunoprecipitation sequencing (ChIP-seq) demonstrated that
BRG1 played a repressive role in transcriptional regulation by modulating the acetylation levels of H3K27 at the enhancers of lineage-
specific genes. Our data thus provide valuable insights into molecular mechanisms by which transcriptional repression affects the
self-renewal and differentiation of hESCs.INTRODUCTION
Embryonic stem cells (ESCs) are originally derived from
the inner cell mass. They are pluripotent cells that can self-
renew anddifferentiate intomultiple cell types upon appro-
priate stimuli. Mouse ESCs (mESCs) possess a distinctive
global chromatin structure that is characterized byhyperdy-
namic plasticity and bivalent domains marked by both
active H3K4me3 (trimethylation of histone 3 lysine 4) and
repressive H3K27me3 (trimethylation of histone 3 lysine
4) in the promoter regions of lineage-specific genes (Bern-
stein et al., 2006; Meshorer et al., 2006). In human ESCs
(hESCs),H3K4me1 (monomethylation at lysine 4ofhistone
3),H3K27ac (acetylation at lysine27 of histone 3), andp300
marked chromatin loci were recently identified as active en-
hancers that drive gene expression (Rada-Iglesias et al.,
2011). Conversely, a lack of H3K27ac but enrichment with
H3K27me3 is linked to repressed but ‘‘poised’’ elements
for genes active in early development (Rada-Iglesias et al.,
2011). The switch from self-renewal to differentiation re-
quires the participation of multiple epigenetic factors,
including chromatin regulators, noncoding RNAs, and his-
tone modifiers (Surani et al., 2007; Tay et al., 2008).460 Stem Cell Reports j Vol. 3 j 460–474 j September 9, 2014 j ª2014 The AOne of these factors, SWI/SNF, is a large chromatin-re-
modeling complex that contains either BRG1 or BRM
exclusively as the catalytic ATPase subunit that drives
the alteration of DNA-nucleosome structure and thus reg-
ulates gene transcription (Fryer and Archer, 1998; Trotter
and Archer, 2008; Wang et al., 1996). Previous studies re-
vealed that deletions of BRG1 or core subunits of the SWI/
SNF complex, such as BAF155 and BAF47, led to peri-im-
plantation lethality due to compromised survival of
totipotent cells that give rise to both the inner cell mass
and trophoblast, suggesting a requirement of the SWI/
SNF complex for totipotency in vivo (Bultman et al.,
2005; Kim et al., 2001; Klochendler-Yeivin et al., 2000).
In addition, deficiency of SWI/SNF components also
affects the developmental potential of various types of
cells (e.g., neurons, hematopoietic cells, and germ cells)
(Chi et al., 2003; Gebuhr et al., 2003; Griffin et al.,
2008; Hang et al., 2010; Kim et al., 2012; Wang et al.,
2012; Yoo and Crabtree, 2009), supporting the notion
that the SWI/SNF complex plays a role in tissue develop-
ment. Recently, a series of reports demonstrated that the
SWI/SNF complex also plays a role in the pluripotency
of mESCs. Deficiency of BRG1, BAF155, or BAF250a/buthors
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entiate into three germ layers (Gao et al., 2008; Ho et al.,
2009a, 2009b, 2011; Kaeser et al., 2008; Kidder et al.,
2009; Schaniel et al., 2009; Yan et al., 2008). Chromatin
immunoprecipitation-coupled DNA sequencing (ChIP-
seq) revealed that BRG1 colocalizes with core pluripotent
factors (OCT4 and SOX2) at a large number of loci in
target genes to fine-tune their regulation. In addition,
BRG1 also potentiates LIF/STAT3 signaling in mESCs by
opposing polycomb (PcG) function via alteration of
H3K27me3 levels (Ho et al., 2009a, 2009b, 2011; Kidder
et al., 2009).
The mammalian SWI/SNF complex contains 15 core
subunits called BRG1- or BRM-associated factors (BAFs),
including several ones not found in yeast (Kadoch et al.,
2013). Different assemblies of BAF components have
been implicated in their tissue-specific functions (Wu
et al., 2009). For instance, BAF60c, but not BAF60b, pro-
tein is selectively expressed in embryonic heart, and its
deficiency results in defective cardiac development and
embryonic lethality at 10–11 days postcoitum (dpc) (Lick-
ert et al., 2004). In mESCs, BRG1 (but not BRM) and
BAF155 (but not BAF170) are enriched with BAF60a to
form the so-called ‘‘esBAF’’ complex (Ho et al., 2009b).
Deficiency of either BRG1 or BAF155 leads to a loss of
pluripotency in mESCs that cannot be rescued by overex-
pression of BAF170 (Ho et al., 2009b). Thus, the specific
composition of the BAF is critical for its function in
mESCs.
Although hESCs and mESCs share a number of core
pluripotency-related transcription factors and cellular
characteristics, hESCs differ remarkably in their clone
morphology, cell-doubling time, responses to signal mole-
cules, and culture conditions required for self-renewal. This
may result in part from their distinct developmental stages
and perhaps from an intrinsic human-mouse divergence.
To date, only a few genes have been identified as sharing
conserved roles in both hESCs and mESCs. The precise
role played by the SWI/SNF complex in hESCs remains
unclear. We thus sought to explore the functional rele-
vance of the SWI/SNF complex in hESC pluripotency.
Here, we demonstrated that knocking down either BRG1
or BAF170 instead of BAF155 led to the loss of pluripotency
of hESCs and dysregulated lineage specification. Genome-
wide arrays revealed a general upregulation of gene expres-
sion resulting from BRG1 deficiency, suggesting that BRG1
plays a repressive role in transcriptional regulation in
hESCs. Further analyses showed that H3K27ac levels of
lineage-specific genes were dramatically increased upon
BRG1 knockdown, highlighting H3K27ac as an important
marker to distinguish active from repressed gene loci in
hESCs. Our study thus provides important functional
and mechanistic insights into the role of the BRG1-SWI/Stem CellSNF complex in regulating the pluripotency of hESCs by
transcriptional repression of genes involved in early
development.RESULTS
BRG1 Deficiency Impairs the Self-Renewal of hESCs
To investigate the importance of the SWI/SNF complex in
hESCs, we established stable BRG1 knockdown lines that
allowed us to evaluate the long-term effects of BRG1 deple-
tion. At the end of the first passage after BRG1 knockdown
for 7 days, the colonies with BRG1 depletion were appar-
ently unable to maintain a normal stem cell phenotype
in culture (Figure 1A). Consistent with this observation,
the percentage of Tra-1-60+ or Tra-1-81+ cells was also
remarkably decreased (Figure 1B; Figures S1A–S1C available
online). In addition, most colonies totally lost alkaline
phosphatase (AP) staining upon BRG1 depletion, and ami-
nority of cells stained positive in themiddle of the colonies
(Figure 1A). By the end of the second passage, 14 days after
BRG1 knockdown, there were few discernible AP+ colonies
in culture, with Tra-1-60+ or Tra-1-81+ cells reduced to
20%–40% (Figures 1B and S1A–S1C). In contrast, we did
not detect any obvious differentiation phenotype upon
depletion of BRM (Figure S1A). Collectively, these data sup-
port an essential requirement of BRG1, but not BRM, for
hESC maintenance.
Notably, although the colonies rapidly lost ESC proper-
ties upon BRG1 knockdown, the expression of pluripo-
tency-related core transcription factors such as OCT4
and NANOG remained unchanged at both the transcript
and protein levels (Figures 1C and 1D). Alterations in the
expression of these pluripotency markers became apparent
only after prolonged loss of BRG1 for 14 days (Figure 1D).
By contrast, the levels of key genes required for early
germ-layer differentiation (Wang et al., 2008), especially
those involved in the mesoderm (BRAYCHURY/T and
MIXL1) and trophectoderm (CDX2 and EOMES), signifi-
cantly increased 48 hr after transient BRG1 knockdown
(Figure 1E). By day 7, the expression of many genes
required for germ-layer differentiation, as well as several
important signaling factors (such as LEFTY1, SMAD3, and
NODAL), was increased remarkably before any significant
alteration of core pluripotency-related genes, such as
OCT4 and NANOG, was observed (Figure 1F). Therefore,
it is unlikely that BRG1 affects the expression of these genes
in early development via downregulation of OCT4 and
NANOG.
ESCs are known to lack cyclin D-associated kinase activ-
ity, which may contribute to their characteristic cell-cycle
profile with a shortened G1 phase and high percentage of
cells at S phase (Becker et al., 2006; Neganova et al., 2009;Reports j Vol. 3 j 460–474 j September 9, 2014 j ª2014 The Authors 461
(legend on next page)
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hESCs was significantly altered at approximately day 14 af-
ter BRG1 knockdown, withmore cells arresting at G1 phase
and fewer cells having progressed through S phase (Fig-
ure 1G). Consistent with these data, the expression levels
of two important cell-cycle regulators, p18 and CCND2,
were increased in BRG1-deficient ESCs (Figures 1H, 1I,
and S1E). In addition, ChIP analyses in hESCs demon-
strated that BRG1 was specifically enriched at 540 bp and
908 bp upstream of the transcription start sites (TSSs) in
the promoter regions of p18 and CCND2, respectively, sug-
gesting that BRG1 directly regulates these two genes (Fig-
ure 1J). Collectively, these results suggest that BRG1 defi-
ciency compromises the cell-cycle progression of hESCs.
BRG1 Deficiency Compromises the Differentiation
Potential of hESCs
In order to examine whether BRG1 affects the differentia-
tion potential of hESCs, embryoid bodies (EBs) were
produced following BRG1 depletion. Compared with
scrambled small hairpin RNA (shRNA) controls, the
BRG1-deficient EBs appeared to be smaller (Figure 2A).
Gene-expression analyses demonstrated that the BRG1-
depleted EBs did not differentiate properly and showed
significantly increased neuron ectoderm (PAX6 and
NESTIN) and moderately enhanced endoderm (SOX17,
FOXA2, and CDX2) formation, whereas the mesoderm lin-
eages (BRACHYURY/T, MIXL1, and GATA6) appeared to be
hindered at different time points during EB development
(Figure 2B).
Consistent with these in vitro results, teratomas that
formed from BRG1-deficient hESCs mainly contained
pigmented neural epithelia and, to a lesser degree, intesti-
nal endothelial cells. Conversely, mesoderm-derived line-Figure 1. BRG1 Deficiency Impairs Self-Renewal of hESCs
(A and B) Morphology and AP staining (A) and flow-cytometry analys
knockdown. Scale bars, 400 mm.
(C and D) Expression of pluripotency-related transcription factors wa
hESCs with shRNA knockdown at day 7 or day 14 (D) by real-time RT-
(E and F) Quantitative gene expression on samples with siRNA knockd
ectoderm; End, endoderm; TE, trophectoderm; Meso, mesoderm.
(G) Cell-cycle profiles of control and BRG1-deficient hESCs analyzed b
(H) Real-time RT-PCR analyses on cell-cycle regulators upon transient
control.
(I) Western blots on control and BRG1-depleted hESCs with antibodie
(J) ChIP-PCR analyses with an antibody against BRG1 in different pro
p18 and two CCND2 primers were used. The number in the primer nam
TSS. Fold changes for percentage of input are presented relative to
scrambled siRNAs or shRNAs; BRG1 KD, samples with siRNAs or shRNA
Four different shRNAs against BRG1 were used in this study and yielde
(E, H, J, and the lower panel in F) are presented as the average of six
*p < 0.05, **p < 0.01. Data in the upper panel of (F) are the average o
Also see Figure S1.
Stem Cellages (such as smooth muscle, bone, and cartilage) were
hardly detectable (Figure 2C). Immunohistochemistry
(IHC) analysis further confirmed the reduced expression
of BRACHYURY (mesoderm), whereas the ectoderm
(b-TUBULIN) and endoderm (FOXA2) markers were largely
unaffected (Figure 2D). Taken together, these results re-
vealed that the mesendodermal differentiation potential
was markedly impaired in BRG1-deficient hESCs.
The BRG1-SWI/SNF Complex Contains both BAF170
and BAF155 in hESCs
Previous reports suggested that the unique composition of
BAFs defines their specific functions (Wu et al., 2009).
BAF155 (but not BAF170) forms homodimers in the mouse
esBAF complex and plays an important role in the self-
renewal of mESCs (Ho et al., 2009b). To determine the pre-
cise composition of the BRG1-SWI/SNF complex in hESCs,
we performed gel-filtration analyses. We observed that
both BAF170 and BAF155 were found with BAF250A,
BAF57, BAF53A, and BAF47 in BRG1-enriched fractions/
complexes in this assay (Figure 3A), constituting a different
pattern compared with that reported for mESCs (Ho et al.,
2009b). We further performed a coimmunoprecipitation
(coIP) assay with an antibody against BRG1, followed by
mass spectrometry analyses (Figure 3B). Using spectra
counts as a measure for relative protein abundance, we
found that BRG1, BAF155, BAF170, BAF60A, and
BAF250A were enriched with BAF53A and BAF47 in this
assay (Figure 3C). These proteins contributed to more
than 80% of the total identified spectra counts of the
SWI/SNF complex in hESCs, whereas the levels for
BAF250B, BAF200, BAF180, and BAF60C, as well as
BCL11A/B (the newly identified BAF subunits in human
T leukemia cells; Kadoch et al., 2013), were relatively lowes (B) of Tra-1-81 in hESC colonies at day 7 or day 14 after shRNA
s examined on samples with transient siRNA knockdown (C) or on
PCR (histogram) or by western blots.
own (E) or shRNA knockdown at day 7 (F) by real-time RT-PCR. Ect,
y flow cytometry at day 14 after BRG1 knockdown.
siRNA BRG1 knockdown for 48 hr compared with a scrambled siRNA
s against CCND2 and p18 at day 14 after BRG1 knockdown.
moter regions of p18 and CCND2 in untreated hESCs. Three different
es indicates the distance of the amplified region upstream from the
the immunoglobulin G (IgG) control. SCR, control samples with
s against BRG1.
d similar results. Individual shRNA is labeled as #3 or #4. PCR data
biological replicates ± 1 SEM from three independent experiments;
f biological duplicates ± 1 SEM from one representative experiment.
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Figure 2. BRG1 Deficiency Compromises
the Differentiation Potential of hESCs
(A) Morphology of EBs from control and
BRG1 knockdown hESCs. Scale bar, 400 mm.
(B) Quantitative RT-PCR for expression of
genes involved in three-germ-layer forma-
tion at different time points (day 11 and day
16) during EB differentiation from control
and BRG1 knockdown hESCs. All RT-PCR data
are presented as the average of six biolog-
ical replicates ± 1 SEM from three inde-
pendent experiments; *p < 0.05, **p < 0.01.
(C) Histological studies of teratoma sec-
tions from control and BRG1-depleted
hESCs.
(D) IHC on teratoma sections with anti-
bodies against the markers for endoderm
(endo), mesoderm (meso), or ectoderm
(ecto) derivatives. Scale bars, 200 mm.
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confirmed these results by coIP assays. Particularly, we
found that both BAF155 and BAF170 were pulled down
with BRG1, and BAF170 and BRG1 were copurified with
BAF155 from hESCs (Figure 3D). Taken together, these re-
sults revealed a unique composition of the BRG1-SWI/
SNF complex in hESCs containing both BAF155 and
BAF170.
The Unique BRG1-SWI/SNF Composition Is Critical
for Self-Renewal of hESCs
To investigate whether this unique assembly of the SWI/
SNF complex is critical for maintaining the pluripotency
of hESCs, we knocked down individual SWI/SNF compo-
nents by RNAi. To our surprise, we observed no obvious dif-
ferentiation phenotype (as indicated by morphology, AP464 Stem Cell Reports j Vol. 3 j 460–474 j September 9, 2014 j ª2014 The Astaining, expression of OCT4, and surface antigen ana-
lyses) upon BAF155 knockdown (Figures 4A–4C, S2A, and
S2B). This result was confirmed by several independent as-
says with different shRNAs against BAF155 (Figure S2A).
Instead, BAF170 deficiency led to a detectable differentia-
tion of hESCs (Figure 4A). The differentiation phenotype
upon BAF170 knockdown was further validated by the
loss of AP staining at the edges of the ESC colonies, reduced
expression of OCT4, and decreased percentage of Tra-1-60+
or Tra-1-81+ cells (Figures 4A–4C and S2B).
To exclude the possibility that the differentiation phe-
nomena observed upon BAF170 deficiency were caused
by off-target effects of RNAi, we introduced BAF170 or
BAF155 cDNAs into hESCs containing a scrambled shRNA
or an shRNA against BAF170 (Figure S2C). Notably, we
observed that BAF155 overexpression could not rescueuthors
ABRG1
BR
G1
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BAF250
B
BRG1
14 16 18 20 22 24 26 28 30
BAF250A
BAF170
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BAF47
BAF170
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BAF170
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Figure 3. Determination of BRG1-SWI/SNF Composition in
Wild-Type hESCs
(A) Gel-filtration analyses of hESCs blotted with antibodies against
BRG1 or other BAF subunits.
(B) Silver-stained images of a BRG1 pull-down sample.
(C) Relative protein abundance of SWI/SNF components immuno-
precipitated with BRG1, calculated according to their spectra
counts. Red, the most abundant; blue, the least abundant.
(D) CoIP with antibodies against either BRG1 or other BAF subunits
on hESCs. Antibodies for western blots are indicated to the left of
the panels.
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down, but ectopic overexpression of BAF170 could (Fig-
ure 4D). This finding explicitly demonstrated that the
BAF170-containing BRG1-SWI/SNF complex was required
for the self-renewal of hESCs.
Recent studies showed that hESCs exist in a primed
pluripotent stage, similarly to mouse epiblast stem cells
(mEpiSCs), whereas mESCs represent a pluripotent popula-
tion in a naive state (Brons et al., 2007; Tesar et al., 2007).
To determine whether this unique assembly of the BRG1-
SWI/SNF complex in hESCs is actually due to their more
advanced developmental stage compared with mESCs, we
investigated the roles of individual BRG1-SWI/SNF compo-
nents inmESCs and EpiSCs by RNAi (Figures S3A–S3C).We
observed that knocking downBRG1 or BAF155, rather thanStem CellBAF170, led to the loss of the pluripotent features in both
naivemESCs and primedmEpiSCs (Figure 4E), thereby sup-
porting a unique roll for t BAF170 in the BRG1-SWI/SNF
complex in hESCs.
BRG1 Deficiency Affects a Broad Range of Biological
Processes in hESCs
To elucidate how the SWI/SNF complex functions in
hESCs, we knocked down BRG1 by transient transfection
of small interfering RNAs (siRNAs) against BRG1 in both
mESCs and hESCs (Figure 5A), compared their gene-expres-
sion profiles with microarray analyses, and further vali-
dated the results by real-time RT-PCR assays (Figures 5B
and 5C).
We identified 631 genes that were altered upon BRG1
depletion in hESCs and further classified them according
to their functions and pathways using Ingenuity Pathway
Analysis (IPA). These genes were associated with more
than 20 categories of biological functions above the
threshold, the most overrepresented of which included
cancer, cellular/embryonic development, nervous system
development, cell death and survival, and tissue
morphology (Figures 5D and S4). Consistent with these
functional distributions, the top-ranked networks were
associated with neurological disorders, cellular organiza-
tion, and cell-to-cell interactions and signaling (Figures
5D and S4). Specifically, genes important for cell-cycle regu-
lation (e.g., CCND2 and CDKL3) and lineage development
(e.g., EOMES, ZIC1, and OSR2) were significantly altered in
BRG1-deficient hESCs, in agreement with our findings
regarding the role of BRG1 in regulating the self-renewal
and pluripotency of hESCs. In addition, BRG1 regulated
many genes that are involved in metabolism, such as
ALDH1A1, CYP2B1/2B6/2R1, LRAT, AKR1C1/C3, and
RDH10 (Figure 5B; Table S1). We also noticed that several
molecules involved in cell adhesion, such as cadherins
(PCDH20, PCDH18, and PCDH15) and GJB5, were
decreased in BRG1-deficient hESCs (Table S1). Collectively,
these data demonstrated that BRG1 participated in a broad
range of biological processes in hESCs in addition to its role
in maintaining hESC self-renewal and differentiation.
Among thegenes thatwere affectedbyBRG1deficiency in
hESCs, only a small set (52 out of 631) was also altered in
mESCs upon BRG1 knockdown (Figure 5E). In addition,
although most of the functional categories affected by
BRG1 depletion were similar between hESCs and mESCs,
the exact pathways and genes that were perturbed were
quite different (Figure S4A). For example, several genes
involved in embryonic development (such as SP8, EOMES,
TREM2, and LIM2) and cell-cycle regulation (such as
CCND2) were altered differentially upon BRG1 knockdown
inhESCs andmESCs (Figure 5F). Interestingly,we further re-
vealed that half of these genes (e.g., TNFAIP6, GRRP1, CD2,Reports j Vol. 3 j 460–474 j September 9, 2014 j ª2014 The Authors 465
Figure 4. Unique BRG1-SWI/SNF Composition Is Important to Maintain the Stem Cell Phenotype of hESCs
(A) Morphology and AP staining of hESC colonies upon knockdown of BAF155 or BAF170 in hESCs.
(B) Expression of BAF components, OCT4, and NANOG was examined by western blotting upon knockdown of BAF155 or BAF170 in hESCs.
(legend continued on next page)
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tion in hESCs from mEpiSCs (Figure 5F), indicating an
intrinsic human-mouse divergence for pathways regulated
by BRG1 in stem cells at the same primed stage.
BRG1 Plays a Repressive Role in Transcriptional
Regulation in hESCs
Frommicroarray analyses, we identified that 427 out of 579
genes that were differentially expressed upon BRG1 defi-
ciency were upregulated (Figure 6A), suggesting that
BRG1 primarily plays a repressive role in hESCs. Recent
reports demonstrated that active enhancers (class I) in
hESCs were marked by H3K4me1, H3K27ac, and p300
binding (Rada-Iglesias et al., 2011). In contrast, the
‘‘poised’’ enhancers (class II) for genes expressed in early
development were characterized by a lack of H3K27ac
(Rada-Iglesias et al., 2011).We interrogated these published
ChIP-seq data and revealed that 33.5% of class II enhancers
were colocalized within ±250 bp of BRG1-binding peaks
(Table S3). Since a high H3K27ac level marks active gene
expression, we further explored whether BRG1 could
repress the expression of lineage-specific genes by affecting
histone acetylation.
We performed genome-wide ChIP-seq analyses using an
antibody specifically against H3K27ac on control and
BRG1-depleted hESCs around day 7 after knockdown
before the expression of key pluripotency factors (e.g.,
OCT4 and NANOG) was altered. We observed that
H3K27ac levels within 5 kb of the TSS of 5,914 genes
were upregulated upon BRG1 knockdown compared with
scrambled control cells (Table S5). We observed that
H3K27ac levels within 5 kb of the TSS of 5,914 genes
were upregulated upon BRG1 knockdown compared with
scrambled control cells but were downregulated in only
623 genes (Table S5), thus demonstrating that BRG1 deple-
tion led to a general elevation of H3K27 acetylation levels.
We further compared the H3K27ac status in enhancer re-
gions of published class II genes according to the en-
richment of BRG1 in control and BRG1-depleted hESCs
(Rada-Iglesias et al., 2011). Interestingly, we found that
the increase of H3K27ac levels was more obvious at the
loci that overlapped with BRG1-binding regions (Fig-
ure 6B), suggesting that the elevated H3K27ac levels in
enhancer regions were indeed BRG1 dependent.
The genes with an increased H3K27ac level in the
enhancer regions included those that are important for dif-
ferentiation into trophectoderm (EOMES), neurons (LHX4,(C) Flow-cytometry analyses of the surface marker Tra-1-81 on hESCs
(D) Morphology of hESC colonies upon BAF170 knockdown and/or exp
Ctrl, empty vector control for overexpression analyses.
(E) Morphology of colonies from mESCs and mEpiSCs upon depletion
Scale bars in (A), (D), and (E), 400 mm. See also Figures S2 and S3.
Stem CellPAX6, ZIC1, and SLITRK3), mesoderm (MIXL1 and GSC),
and endoderm (FOXA2), and signal molecules that are
important for mesendodermal development (NODAL,
LEFTY1/2, andWNT3) (Figures 6C, 6D, S5E, and S5F; Table
S5). Their increased H3K27ac levels were confirmed by
independent ChIP-PCR analyses (Figure 6D). Notably,
correlating with their elevated H3K27ac status, the expres-
sion of these genes was upregulated upon BRG1 depletion
as well (Figures 1E, 1F, and 5C). We further determined the
BRG1-binding intensity in these enhancer regions by per-
forming ChIP-PCR assays with an antibody against BRG1.
Indeed, we observed a significant enrichment of BRG1 in
the same regions with elevated H3K27ac levels (Figure 6E),
thus proving that BRG1 depletion is responsible for
increased H3K27 acetylation at these enhancers of genes
that are active in development, and may in turn lead to
their upregulated transcriptional activation.DISCUSSION
Although both mESCs and hESCs are derived from the
inner cell mass of blastocysts, they differ remarkably in
terms of colony morphology, cell-doubling time, and the
signaling pathways that maintain their self-renewal capac-
ity. The extent to which these differences are observed at a
molecular level remains only partially described. The
recent generation of primed EpiSCs has added another
layer of complexity (Brons et al., 2007; Tesar et al., 2007).
Although hESCs share some defining features with mE-
piSCs in terms of growth properties and signaling re-
sponses, they differ from mEpiSCs in several aspects (De
Los Angeles et al., 2012). For instance, hESCs express
REX1, a marker associated with naive mESCs, but do not
express FGF5, a key mEpiSC marker (Greber et al., 2010).
These differences further complicate efforts to simply
extrapolate the rodent paradigm to humans. In the case
of the SWI/SNF complex, the nature and importance of
its role in hESCs is an important area of investigation. In
this study, we found that depletion of the major catalytic
subunit of the SWI/SNF complex, BRG1, compromised
the self-renewal capacity of hESCs and their murine coun-
terparts, mESCs and mEpiSCs. In addition, BRG1 defi-
ciency impaired mesodermal development from hESCs,
as revealed by both in vitro EB differentiation and in vivo
teratoma formation. We further demonstrated that BRG1
participated in a broad range of biological processes inupon depletion of BAF155 or BAF170.
ression of V5-tagged BAF155 or BAF170 cDNAs. OE, overexpression;
of individual SWI/SNF components.
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Figure 5. BRG1 Depletion Affects a Broad Range of Biological Processes in hESCs
(A) Knockdown of BRG1 in hESCs and mESCs was verified by western blots.
(B and C) Quantitative RT-PCR validation for genes differentially expressed in microarray analyses. RNA samples were collected from either
mESCs (B) or hESCs (C) transfected with siRNAs against BRG1.
(D) Genes affected by BRG1 knockdown in hESCs were analyzed by IPA according to their functions.
(legend continued on next page)
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BRG1 Affects Pluripotency via Histone AcetylationhESCs through genes and pathways distinct from those of
mESCs andmEpiSCs, thus indicating that BRG1 differently
regulates the pluripotency of stem cells across species. Our
data define an essential and conserved role of BRG1 in ESC
biology, and also provide mechanistic insights into how
the BRG1-mediated SWI/SNF complex affects the mainte-
nance of human stem cells.
The SWI/SNF complex consists of 15 core subunits whose
unique composition is critical for its distinct functions in
different types of cells (Kadoch et al., 2013; Wu et al.,
2009). In our study, we demonstrated that both BAF170
and BAF155 existed in the human BRG1-SWI/SNF complex
and were enriched with BRG1, BAF53A, and BAF47. Deple-
tion of BAF170 instead of BAF155 led to the loss of stem cell
properties in hESCs. This pattern is different from that
observed in their rodent counterparts (i.e., mESCs and mE-
piSCs), suggesting an intrinsic functional divergence of
BAF components between human and mouse. Although
BAF155 and BAF170 share more than 60% homology in
their protein sequences, their functions are not inter-
changeable. BAF155 is unable to correct the differentiated
morphology caused by BAF170 depletion in hESCs. Simi-
larly, knockdown of BAF53A, but not BAF53B, led to
obvious differentiation of hESCs (Figure S2D). It is plausible
that the BAF170- and BAF53A-containing SWI/SNF com-
plex interacts with different partners in hESCs from
BAF155 and in turn regulates a distinct set of target genes
that are important for pluripotency.
OCT4, SOX2, and NANOG are core pluripotency-related
transcription factors that maintain undifferentiated phe-
notypes of ESCs (Boyer et al., 2005). Our study demon-
strated that BRG1 deficiency did not lead to any immediate
alteration in expression of OCT4, SOX2, or NANOG.
Changes in the protein levels of these pluripotency
markers became apparent only after prolonged depletion
of BRG1 (Figures 1C and 1D). By contrast, significantly
increased expression of genes that are important for tro-
phectodermal and mesendodermal lineage development
was observed at the early stage of BRG1 knockdown.
Several of those genes (e.g., EOMES, GSC, FOXA2, NODAL,
LEFTY1/2, and WNT3) were direct targets regulated by
BRG1 through modulation of H3K27ac levels, thus
providing insights into epigenetic regulation during
human embryogenesis. In addition, our data demonstrate
that BRG1 participates in a broad range of biological func-
tions of hESCs, including cell cycle, cell-to-cell interac-(E) Venn diagram with the numbers of genes affected by BRG1 knoc
indicates the number of common genes altered in both hESCs and mE
(F) Expression levels of the same set of genes upon BRG1 depletion i
changes of expression relative to their own scrambled shRNA control
All PCR data are presented as the average of six biological replicates ±
See also Figure S4.
Stem Celltions, and metabolism. Therefore, it is plausible that
reduced expression of these pluripotency-related factors is
secondary to prolonged cellular abnormalities and differ-
entiation. Nevertheless, we cannot exclude the possibility
that BRG1 coregulates target genes of OCT4 or NANOG.
We interrogated the published ChIP-seq data using anti-
bodies against BRG1, OCT4, or NANOG (Figure S6A).
About 40% of OCT4-bound loci and 18%–38% of
NANOG-occupied regions were enriched with BRG1 using
±250 bp as a cutoff distance between BRG1 and OCT4- or
NANOG-enriched peak centers (Figure S5A). Although
BRG1 colocalizes extensively with OCT4 and NANOG in
hESCs, the overlap is far less than that in mESCs (Ho
et al., 2009a), highlighting the different regulatory net-
works between human and mouse cells.
A balance between gene activation and repression is
crucial for multiple biological or pathological processes.
This balance is mainly regulated through changes in chro-
matin structure imparted by DNA methylation, chromatin
remodeling, and histonemodifications. DNAmethylation,
histone deacetylation, and certain histone methylations
(such as H3K27me3) are often associated with transcrip-
tional repression (Perissi et al., 2010). In mESCs, BRG1
and PcG components such as EZH and SUZ12 co-occupy
many of the OCT4/SOX2 target genes, and BRG1 opposes
PcG activity by altering H3K27me3 levels (Ho et al.,
2011). In hESCs, however, BRG1 depletion did not result
in any significant changes of H3K27me3 levels in either
the promoter or enhancer regions of upregulated lineage-
specific genes such as EOMES and FOXA2 (Figures S5B–
S5D). In contrast, we observed a significant increase of
genome-wide H3K27ac levels upon BRG1 knockdown in
the enhancer regions that become active in early develop-
ment. This increase was detected in the majority of these
enhancer regions (such as those for EOMES, FOXA2,
LEFTY2, and NODAL) after transient BRG1 depletion for
3 days (Figure S6A). These data thus suggest that the eleva-
tion of H3K27ac levels is BRG1 dependent and likely a
direct consequence of BRG1 depletion. We also observed
an upregulation of the acetyl-H3 level in the promoter re-
gions for about 60%of the genes we examined (Figure S6B),
which was correlated with their activated transcription.
However, the increase for H3K9ac was much less obvious
(Figure S6C), indicating a specificity for H3K27ac in the
enhancer regions regulated by BRG1. In addition, no
obvious alteration in the levels of acetyl-H3, acetyl-H4, orkdown in hESCs and mESCs. The number in the overlapping circles
SCs upon knockdown.
n hESCs, mESCs, or mEpiSCs examined by quantitative RT-PCR (fold
s).
1 SEM from three independent experiments; *p < 0.05, **p < 0.01.
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Figure 6. BRG1 Plays a Repressive Role in Transcriptional Regulation in hESCs
(A) Percentage of upregulated and downregulated genes upon knockdown of BRG1 in hESCs, based on microarray data.
(B) H3K27ac levels in control (SCR) and BRG1 knockdown (KD) hESCs were examined in class II enhancer regions, which were divided into
two groups according to their overlap with BRG1-binding peaks. The genomic regions of the enhancers were divided equally into ten bins
(shown as the x axis). The normalized read counts of H3K27ac ChIP-seq data for each bin (shown as the y axis) was calculated by the reads
(legend continued on next page)
470 Stem Cell Reports j Vol. 3 j 460–474 j September 9, 2014 j ª2014 The Authors
Stem Cell Reports
BRG1 Affects Pluripotency via Histone Acetylation
Stem Cell Reports
BRG1 Affects Pluripotency via Histone AcetylationH3K27ac modification was detected upon BRG1 depletion
by western blots (Figure S6D), suggesting a regulatory spec-
ificity of BRG1 on H3K27ac in enhancer regions. Collec-
tively, our data support the notion that BRG1 inhibits the
transcription of lineage-specific genes by specifically
modulating H3K27ac levels in hESCs. In this context, it is
noteworthy that in several previous reports, BRG1 was
shown to be associated with histone acetyltransferases
(such as p300/CBP) (Huang et al., 2003) or histone deacety-
lases containing corepressor complexes (such as SIN3A)
(Liang et al., 2008; Pal et al., 2003; Underhill et al., 2000).
It will be of great interest to systematically dissect which co-
activator or corepressor complex associates with BRG1 to
regulate histone acetylation during early development.
Nevertheless, the present study suggests a mechanism by
which the BRG1-SWI/SNF complex negatively regulates
gene transcription, and clearly illustrates the functional
differences between the epigenetic machineries present in
hESCs and mESCs that are important for pluripotency.EXPERIMENTAL PROCEDURES
ESC and Epiblast Stem Cell Culture and
Differentiation
Mouse ESCs were maintained as previously described (Wang et al.,
2005). hESC lines H1 and BG01 (WiCell Research Institute) were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)/F12
supplemented with 20% knockout serum replacement (KSR) and
4 ng/ml FGF2 (all from Invitrogen). mEpiSCs were derived from
the epiblast of embryos at 5.5 dpc according to standard protocols
(Brons et al., 2007; Tesar et al., 2007). The mEpiSCs were main-
tained routinely according to the same protocol and in the same
medium used for hESCs. For EB formation, clumps of hESCs
were transferred into petri dishes with DMEM/F12 containing
20% KSR. The medium was changed every other day.
AP Assay
AP staining was performed with the BCIP/NBT Alkaline Phospha-
tase Kit (Beyotime) according to the manufacturer’s instructions.
Flow-Cytometry Analyses
Forcell-cycleanalyses, cellswerefixedwith70%ethanol at4Cover-
night and incubated in PBS containing 100 mg/ml ribonuclease A
and 20 mg/ml propidium iodine for further analysis. Cell-cycle pro-in that region divided by the total reads in that library (SCR versus B
sequencing coverage.
(C) The H3K27ac ChIP-seq signals from SCR control and BRG1 KD hES
H3K4me1 signals based on the UCSC custom track deposited by the E
(D) ChIP-PCR assays with an antibody against H3K27ac were performe
and cells with BRG1 depletion.
(E) ChIP-PCR assays with control IgG or an antibody against BRG1 in
All PCR data are presented as the average of six biological replicates ±
See also Figures S5 and S6.
Stem Cellfiles collected by flow cytometry were processed with Modfit soft-
ware. For surface antigen analyses, hESCswere stainedwithprimary
antibodies (Tra-1-60 and Tra-1-81; Santa Cruz Biotechnologies),
washedwithPBS, and incubatedwithanAPC-conjugated secondary
antibody (BD Biosciences) for analysis. All flow-cytometry assays
were performed on the FACSCalibur system (BD Biosciences).
Plasmid Construction and RNAi
The siRNAs for transient BRG1 knockdown were purchased from
Santa Cruz Biotechnologies and electroporated into ESCs with
the Nucleofactor Device (Lonza). The shRNAs for knocking down
BRG1 or other BAF subunits were cloned into a lentiviral vector
driven by a human U6 promoter. All shRNA sequences used in
this study are listed in Table S6. To construct expression plasmids,
a cDNA fragment containing either V5-tagged BAF155 or BAF170
was cloned into a PiggyBac vector driven by a CMV promoter.
Drug selection for hygromycin or puromycin driven by the EF1a
promoter in these vectors allowed us to establish stable hESC lines
for long-term shRNA knockdown or cDNA expression.
Western Blots and Gel-Filtration Analyses
Western blots were performed according to standard protocols.
The final blots were incubated with fluorescence-conjugated
secondary antibodies (Li-Cor Odyssey) and signals were read by
the Li-Cor Odyssey system. Superose 6 gel-filtration analyses
(Bio-Rad) were performed as previously described (Yan et al.,
2008). The following primary antibodies were used in this study:
BRG1-G7, BAF155, BAF170, BAF60A, BAF60B, BAF47, BAF57,
and OCT4 (Santa Cruz Biotechnologies); NANOG, H3, and H4
(Cell Signaling Technologies); TUBULIN (Abcam); BAF53A (Bethyl
Laboratories); and acetyl-H3 and acetyl-H4 (Millipore).
CoIP and Mass Spectrometry Analyses
Cells were harvested, incubatedwith primary antibodies for 6 hr at
4C, and precipitated with protein A-agarose beads (Santa Cruz
Biotechnologies). For mass spectrometry analysis, peptides were
extracted from destained SDS-PAGE gel and analyzed on an LTQ
XL (Thermo Fisher Scientific) in data-dependent acquisition
mode. The spectra were analyzed using SEQUEST against the Uni-
prot Swiss-Prot Database and the International Protein Index (IPI)
Human Database (v3.87). BRG1-H88 from Santa Cruz Biotechnol-
ogies was used for the coIP assays.
ChIP and ChIP-Seq Analyses
Cells were fixed in 1% formaldehyde for 10 min at 37C and son-
icated to shear DNA to a length of 200–1,000 bp. Lysates wereRG1 KD) to exclude the potential variation introduced by different
Cs at two representative genomic loci (WNT3 and LHX4) are shown.
NCODE/Broad Institute are shown in grayscale.
d on genes important for lineage differentiation from control hESCs
the same regions described in (D) in wild-type hESCs.
1 SEM from three independent experiments; *p < 0.05, **p < 0.01.
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bodies were added to immunoprecipitate targeted chromatin frag-
ments at 4C overnight. Enrichment of proteins at targeted DNA
fragments was analyzed by real-time PCR. For ChIP-seq analyses,
1–10 ng of ChIP DNA fragments were end repaired, 50 phosphory-
lated, and ligatedwith Illumina adaptors using theOvation SP+Ul-
tralow DR system (NuGen). Adaptor-ligated ChIP DNA fragments
were subjected to 12 cycles of PCR to prepare the final libraries,
which were sequenced with an Illumina HiSeq-2000 Sequencer.
For H3K27ac ChIP-seq data analyses, after raw sequence reads
were demultiplexed, each ChIP-seq sample was aligned to the hu-
man reference genome (hg19) with BWA (Li and Durbin, 2010).
Uniquely mapped reads were analyzed with SICER (Zang et al.,
2009). To identify peaks in each ChIP sample, the corresponding
input was used as a background control. The location and tag den-
sity of the resulting ChIP peaks were visualized by UCSC Genome
Browser. The BRG1 ChIP-seq data for hESCs were downloaded
from the NCBI database (GSM602297) and lifted over to hg19
with the LiftOver tool fromUCSC. The class I and class II enhancer
peak data were obtained from a published report (Rada-Iglesias
et al., 2011) and lifted over to hg19. All ChIP-seq peaks were anno-
tated to the nearest RefGenes (build hg19) from the UCSC genome
browser. ChIP-seq peaks were considered as overlapping when the
distance between the centers of loci was within ±250 bp. For com-
parison between BRG1 ChIP-seq data and microarray data, BRG1
ChIP-seq peaks were annotated to the nearest genes and compared
with the gene list frommicroarray analyses. The antibodies used in
these assays were BRG1 and H3K27ac (Abcam).
Microarray Hybridization and Data Processing
Expression analysis was conducted using Agilent Whole Human
Genome (014850) or Whole Mouse Genome (014868) 4 3 44
multiplex format oligo arrays (Agilent Technologies) according
to the Agilent one-color expression analysis protocol. For each
sample, 1.65 mg of Cy3-labeled cRNAs were fragmented and
hybridized for 17 hr. Slides were scanned with an Agilent
Scanner. Data were obtained and adjusted using the Agilent
Feature Extraction software (v9.5) and further processed with the
Rosetta Resolver system (v7.1) (Rosetta Biosoftware). To identify
genes that were differentially expressed, error-weighted ANOVA
was performed to determine whether there was a statistical differ-
ence between group means with p value < 0.01. Function and
network analyses were performed by IPA (Ingenuity Systems).
RT-PCR and Real-Time PCR
Total RNA was extracted using Trizol (Invitrogen) and cDNA was
synthesized with the SuperScript II First-Strand Synthesis Kit (Invi-
trogen) according to the manufacturer’s protocol. Quantitative
PCR was performed with SYBR Premix Ex Taq (TAKARA) on
Mx3005P (Stratagene). The transcript levels were normalized to
glyceraldehyde 3-phosphate dehydrogenase. All primers used for
RT-PCR and real-time PCR are provided in Table S6.
Teratoma Formation, IHC, and Histological Analyses
Cells were injected subcutaneously into NOD/SCIDmice (53 106
cells per site). Tumorswereprocessed forhematoxylin-eosinstaining
at 8 weeks postinjection, and 4-mm-thick paraffin sections were472 Stem Cell Reports j Vol. 3 j 460–474 j September 9, 2014 j ª2014 The Atreated with xylol and rehydrated in alcohol. The epitopes were
retrieved in citrate buffer at 100C for 30 min. IHC was performed
with the Histostain-Plus IHC Kit (MRBiotech) with the following
antibodies: FOXA2 (Cell SignalingTechnologies), BRACHYURY (Ab-
cam), and b-TUBULIN (Santa Cruz Technologies). All animal exper-
imental procedureswere conducted inaccordancewith the localAn-
imal Welfare Act and Public Health Service Policy and approved by
the animal experiment review board of the Institute of Life Sciences
at East China Normal University (protocol #AR2013/05006).
Statistical Analysis
All data (except formicroarrayandChIP-seqanalyses) arepresented
as groupmeans± SEM, andp valueswere calculatedusing Student’s
t test for comparisons as previously described (Wang et al., 2008).
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